These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10372679)

  • 1. Relative versus attributable risk of breast cancer from estrogen replacement therapy.
    Santen RJ; Petroni GR
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1875-81. PubMed ID: 10372679
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
    Punnonen R
    Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy and breast cancer].
    Mueck AO
    Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Yong SP
    Lancet; 2003 Oct; 362(9392):1331; author reply 1332. PubMed ID: 14575992
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bliss JM; Gray R
    Lancet; 2003 Oct; 362(9392):1328-9; author reply 1330-1. PubMed ID: 14575984
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
    Gapstur SM; Potter JD; Drinkard C; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
    Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
    J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
    Lyytinen H; Ylikorkala O
    Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
    Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy and breast cancer risk: trumping fear with facts.
    Kaunitz AM
    Menopause; 2006; 13(2):160-3. PubMed ID: 16645526
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone and breast cancer.
    Hall SA; Araujo AB; Kupelian V; Maserejian NN; Travison TG
    J Sex Med; 2010 Feb; 7(2 Pt 2):1035-6; author reply 1036-7. PubMed ID: 19878445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F; Huiart L
    J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen replacement therapy and breast cancer].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1045; author reply 1045. PubMed ID: 15852091
    [No Abstract]   [Full Text] [Related]  

  • 18. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.